Edition: Global  
One News Page
“Probably the fastest-access news portal in the world”
> >

U.S. FDA approves biosimilar version of cancer drug Avastin

Reuters Thursday, 14 September 2017 ()
(Reuters) - The U.S. Food and Drug Administration said on Thursday it has approved Amgen Inc's biosimilar version of Roche Holding AG's cancer drug Avastin.
0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 

Recent related news

Amgen challenge to Genentech $6 billion cancer drug OK'd by FDA

A "biosimilar" version of the cancer drug Avastin — Genentech Inc.'s best-selling oncology treatment — was approved Thursday by the Food and Drug...
bizjournals - Business

FDA clears cheaper biotech drug copycats, but buying them isn’t easy

In 2016, Roche sold $3 billion worth of its blockbuster biotechnology drug Avastin. Last week, the Food and Drug Administration approved what’s expected to be...
SFGate - Business

The FDA just approved the first direct competitor to a billion-dollar cancer drug (ROG.VX, AMGN)

The FDA just approved the first direct competitor to a billion-dollar cancer drug (ROG.VX, AMGN)
The FDA just approved a version of Avastin, a blockbuster chemotherapy made by Genentech that brought in $6.7 billion in sales in 2016.  The newly approved...
Business Insider - Business

5 Ways To Play The Biotech Bull Market

This is a bull market, and some biotech stocks are the real raging bulls—especially when massive drug pipelines are at stake, and landmark FDA approvals shake...
OilPrice.com - Markets

Transgene Receives FDA IND Approval to Begin a Clinical Trial with TG4010 + Nivolumab + Chemotherapy in the First-Line Treatment of Lung Cancer (NSCLC)

Transgene Receives FDA IND Approval to Begin a Clinical Trial with TG4010 + Nivolumab + Chemotherapy in the First-Line Treatment of Lung Cancer (NSCLC)
STRASBOURG, France--(BUSINESS WIRE)--#HBV--Regulatory News: Transgene (Paris:TNG), a biotech company that designs and develops viral-based immunotherapies, today...
Business Wire - Press Releases

How Much Does It Really Cost to Develop a Cancer Drug?

A new study concludes it costs $757 million to develop a new cancer drug, but is that the only reason why drugmakers charge sky-high drug prices or are other...
Motley Fool - Markets

A Biosimilar Cure for Sky-High Cancer Drug Prices

The FDA has approved Amgen and Allergan's Mvasi, the first-ever cancer-drug biosimilar to win an OK.
Motley Fool - Markets

FDA Grants “Fast Track” Status to Cancer Prevention Pharmaceuticals’ Lead Drug CPP-1X/sul for Treatment of Familial Adenomatous Polyposis

FDA Grants “Fast Track” Status to Cancer Prevention Pharmaceuticals’ Lead Drug CPP-1X/sul for Treatment of Familial Adenomatous Polyposis
TUCSON, Ariz.--(BUSINESS WIRE)--Cancer Prevention Pharmaceuticals, Inc. (CPP), a private biotech company developing novel therapeutics to prevent cancer and...
Business Wire - Press Releases


You Might Like


Other recent news in Health

Jimmy Kimmel: Senator ‘Lied Right To My Face’ On HEALTH CAREPuerto Rico DIRECT HIT by HURRICANE MARIA... interview with Dane Wigington reveals "weather weaponization" may be the culprit
Study: Most states would take a hit from GOP HEALTH bill

Twitter

pic

Farzana R Hossain MD RT @fr_hossain: U.S. FDA approves biosimilar version of cancer drug Avastin https://t.co/3Ae5x5Kiu6 #drugprices #health #pharmaceuticals… 21 hours ago

pic

Mo-MD RT @fr_hossain: U.S. FDA approves biosimilar version of cancer drug Avastin https://t.co/3Ae5x5Kiu6 #drugprices #health #pharmaceuticals… 22 hours ago

pic

Farzana R Hossain MD U.S. FDA approves biosimilar version of cancer drug Avastin https://t.co/3Ae5x5Kiu6 #drugprices #health #pharmaceuticals #generics 23 hours ago

pic

Zal U.S. FDA approves biosimilar version of cancer drug Avastin https://t.co/yUiO8rOuEU 23 hours ago

pic

Black Swan Analysis US FDA approves biosimilar version of cancer drug Avastin - Reuters https://t.co/3Tng3yH12o via Black Swan Intelligent Insight™ 2 days ago

pic

Dennis J O'Leary, Jr U.S. FDA approves biosimilar version of cancer drug Avastin https://t.co/JlgRzHrPfH 3 days ago

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2017 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+